OTTAWA--(BUSINESS WIRE)--Removing administrative barriers under the Canada-US Tax Treaty for investors such as non-resident venture capital funds are a welcome change, and ease the way for investment in Canadian biotechnology firms according to trade industry association BIOTECanada.
